Farmaprojects
Manufacturing · 51-200 Employees
View Company Info for Free
Overview
Phone Number
+34 935080500Website
www.farmaprojects.esRevenue
$5.2 MillionIndustry
About Farmaprojects
Farmaprojects Org Chart
Is Farmaprojects your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Farmaprojects has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Farmaprojects recently announced quarterly report
Check out if Farmaprojects is spiking on competitors!
Funding: Get notified immidiatlly once Farmaprojects has new funding data
Website visits: Recent activity has been detected on your website
Farmaprojects, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Farmaprojects had a recent Job posting/layoffs
Product Launch: Get notified when Farmaprojects launches new products
Congratulate Masked Content for being promoted to Masked Content at Farmaprojects
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Farmaprojects is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Farmaprojects is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Farmaprojects.
Farmaprojects Tech Stack
A closer look at the technologies used by Farmaprojects
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Farmaprojects
Farmaprojects is the B2B hub of the Polpharma Group, specializing in the pharmaceutical industry with a focus on generics and innovative value-added products. They offer a broad range of medicines across various therapeutic areas and dosage forms, providing flexible business models such as out-licensing and co-developments. With state-of-the-art R&... Read More